Impaired platelet [3H]paroxetine binding in female patients with borderline personality disorder

Psychopharmacology

Volumn 182, Issue 3, 2005, Pages 447-451

  Ng Ying Kin, N M K ^a,b   Paris, Joel ^a,c,e   Schwartz, George ^a,b   Zweig Frank, Hallie ^d   Steiger, Howard ^a,b   Nair, N P V ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Gina Cody School of Engineering and Computer Science   (Canada)

^e NONE   (Canada)

Author keywords

Borderline personality disorder; Paroxetine binding; Personality traits; Serotonergic function

Indexed keywords

PAROXETINE; SEROTONIN; TRITIUM;

ADULT; ARTICLE; BORDERLINE STATE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG BINDING; DRUG LABELING; FEMALE; HUMAN; IMPULSIVENESS; PERSONALITY TEST; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; QUESTIONNAIRE; RATING SCALE; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; THROMBOCYTE; METABOLISM; PALATE; PHYSIOLOGY;

ADULT; BORDERLINE PERSONALITY DISORDER; FEMALE; HUMANS; PALATE; PAROXETINE; SEROTONIN;

EID: 26844493736     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0097-1     Document Type: Article

References (40)

1. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, text edition, 4th edn. American Psychiatric Press, Washington, DC
2. Bakish D, Cavazonni P, Chudzik J, Ravindran A, Hrdina PD (1997) Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol Psychiatry 41:184-190
3. Barrat E (1985) Impulsive subtraits: arousal and information processing. In: Spence JT, Izard CE (eds) Motivation, emotion, and personality. Elsevier, New York, pp 137-146
4. Brown GL, Ebert MH, Goyer PF (1982) Aggression, suicide and serotonin: relationship to cerebrospinal fluid amine metabolites. Am J Psychiatry 139:741-746
5. Buss AH, Durkee A (1957) An inventory for assessing different kinds of hostility. J Consult Psychol 21:343-349
6. Coccaro EF (1989) Central serotonin and impulsive aggression. Br J Psychiatry Suppl 8:52-62
7. Coccaro EF, Kavoussi RJ, Sheline YI, Lish JD, Csernanksy JG (1996) Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Arch Gen Psychiatry 53:531-536
8. DeVegvar M-L, Siever LJ, Trestman RL (1995) Impulsivity and serotonin in borderline personality disorder. In: Silk KR (ed) Biological and neurobehavioral studies of borderline personality disorder. American Psychiatric Press, Washington, DC, pp 23-40
9. Gardner DL, Lucas PB, Cowdry RW (1990) CSF metabolites in borderline personality disorder compared with normal controls. Biol Psychiatry 28:247-254
10. Gardner DL, Leibenluft E, O'Leary KM, Cowdry RW (1991) Self-ratings of hostility and anger in borderline personality disorder. J Nerv Ment Dis 179:157-161
11. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50-55
12. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
13. Hollingshead A, Redlich F (1958) Social class and mental illness. Wiley, New York
14. 3H paroxetine binding to human platelets: clues to a selectivity paradox from temperature studies. Br J Pharmacol 96:303-309
15. Leyton M, Okazawa H, Diksic M, Paris J, Rosa P, Mzengeza S, Young SN, Blier P, Benkelfat C (2001) Brain regional rate a - methyl {11} trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry 158:775-782
16. Livesley WJ, Schroeder ML (1991) Dimensions of personality disorder: the DSM-III-R cluster B diagnoses. J Nerv Ment Dis 179:320-328
17. Mann JJ, McBride PA, Anderson GM, Mieczkoswiski TA (1992) Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology. Biol Psychiatry 32:243-257
18. Marazziti D, Conti L, Pfanner C, Presta S, Rossi A, Gemignani A, Dell'Osso L, Cassano GB (2001) No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients. Neuropsychobiology 43:117-122
19. Martial J, Paris J, Leyton M, Zweig-Frank H, Schwartz G, Teboul E, Thavuyandil J, Larue S, Ng Ying Kin NMK, Nair NPV (1997) Neuroendocrine study of serotonergic sensitivity in female borderline personality disorder patients. Biol Psychiatry 42:737-739
20. 3H-imipramine to rat neuronal membranes. Psychopharmacology 89:436-439
21. 3H-imipramine to human platelet membranes. Eur J Pharmacol 96:303-309
22. Moss HB, Yao JK, Panzak G (1990) Serotonergic responsibility and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry 28:325-338
23. Paris J, Zweig-Frank H, Bond M, Guzder J (1996) Defense styles, hostility, and psychological risk factors in male patients with personality disorders. J Nerv Ment Dis 184:155-160
24. Paris J, Zweig-Frank H, Ng Ying Kin NMK, Schwartz G, Steiger H, Nair NPV (2004) Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls. Psychiatry Res 121:239-252
25. Patkar AA, Gottheil E, Berrettini WH, Hill KP, Thornton CC, Weinstein SP (2003) Relationship between platelet serotonin uptake sites and measures of impulsivity, aggression, and craving among African-American cocaine abusers. Am J Addict 12:432-447
26. 3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity. Psychiatry Res 96:51-61
27. Rinne T, Westenberg HG, den Boer JA, van den Brink W (2000) Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients. Biol Psychiatry 47:548-556
28. 3H]paroxetine binding in depressed patients. J Affect Disord 44:79-85
29. 3H]paroxetine binding sites in platelets from depressed patients. J Affect Disord 52:225-233
30. 18F-fluorodeoxyglcuose positron emission tomography. Neuropychopharmacology 20:413-423
31. Stahl SM (1985) Platelets as pharmacologica models for the receptors and biochemistry of monoaminergic neurons. In: Longneker GS (ed) Platelets: physiology and pharmacology. Academic, Orlando, FL, pp 340-380
32. Stahl SM, Ciaranello RD, Berger PA (1982) Platelet serotonin in schizophrenia and depression. Adv Biochem Psychopharmacol 34:183-198
33. Steiger H, Leonard S, Ng Ying Kin NM, Ladouceur C, Ramdoyal D, Young SN (2000) Childhood abuse and platelet tritiated-paroxetine binding in bulimia nervosa: implications of borderline personality disorder. J Clin Psychiatry 61:428-435
34. Steiger H, Young SN, Kin NM, Koerner N, Israel M, Lageix P, Lehoux P, Paris J (2001) Implications of impulsive and affective symptoms for serotonin function in bulimia nervosa. Psychol Med 31:85-95
35. Steiger H, Israel M, Gauvin L, Ng Ying Kin NM, Young SN (2003) Implications of compulsive and impulsive traits in women with bulimia nervosa. Psychiatry Res 120:219-229
36. 3H-] paroxetine binding in bulimic syndromes. Int J Eat Disord 37:57-60
37. 3H imipramine binding sites and uptake of serotonin in control, depressed and schizophrenic patients. Neuropharmacology 22:1211-1214
38. 3H-paroxetine binding related to impulsive suicide attempts and borderline personality disorder. Biol Psychiatry 43:740-746
39. Zanarini MC, Frankenburg F, Chauncey DL, Gunderson JG (1987) The diagnostic interview for personality disorders: inter-rater and test-retest reliability. Compr Psychiatry 28:467-480
40. Zanarini MC, Gunderson JG, Frankenburg FR (1989) The revised diagnostic interview for borderlines: discriminating BPD from other Axis II disorders. J Personal Disord 3:10-18